Kiniksa Pharmaceuticals, Ltd.
Utility Patents

Last updated:

List of all Kiniksa Pharmaceuticals, Ltd. patents 5 in total

Status Patent
Grant
Utility: Treatment of cytokine release syndrome with GM-CSF antagonists External link
Filling date: 8 Sep 2025 Issue date: 10 May 2022
Grant
Utility: Stable anti-OSMR antibody formulation External link
Filling date: 8 Sep 2025 Issue date: 12 Oct 2021
Grant
Utility: Stable anti-OSMR antibody formulation External link
Filling date: 8 Sep 2025 Issue date: 3 Dec 2019
Grant
Utility: Oncostatin M receptor antigen binding proteins External link
Filling date: 8 Sep 2025 Issue date: 24 Sep 2019
Grant
Utility: Stable anti-OSMR antibody formulation External link
Filling date: 8 Sep 2025 Issue date: 27 Aug 2019

Showing 1 to 5 of 5 patents.